|
|||||
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round 
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own. . . . → Read More: Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M 
A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO  Comments are closed  Finance  biomedical, biotechnology, computer science, engineering, equity, genomics, investment, IPO, life sciences, semiconductors 
Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co . . . → Read More: Gene Silencing Technology Licensed in $3.7B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, Europe, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, clinical trials, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
A company developing a drug delivery technology to treat chronic sinus conditions is raising $29.5 million in its second venture financing round. . . . → Read More: $29.5M Funding Raised for Sinus Drug Delivery Company One comment - (Comments are closed) Finance, New products biomedical, chemistry, clinical trials, engineering, equity, investment, life sciences, materials science, medical device, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics Comments are closed Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, investment, life sciences, pharmaceuticals, U.K., university 
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds Comments are closed Finance, New products behavioral science, biomedical, clinical trials, engineering, entrepreneurs, equity, Europe, investment, licensing, life sciences, medical device, psychiatric, software, U.K., university, venture capital 
A new enterprise that offers electronic health service prescriptions is raising $1.8 million in seed funds and starting a program for prescribing digital health services simultaneously to groups of people. . . . → Read More: Start-Up Offers Digital Health Prescriptions, Raises $1.8M Comments are closed Finance, New products biomedical, engineering, entrepreneurs, equity, investment, medical device, software, university, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
